|
|
DSpace at RU >
Browsing by Author Visser, M. de
Showing results 1 to 44 of 44
| Full Text | Issue Date | Title | Author(s) | | 2011 | Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology | Huisman, M.H.; Jong, S.W. de; Doormaal, P.T. van; Weinreich, S.S.; Schelhaas, H.J., et al |
| 2011 | Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice | Vegt, E.; Melis, M.; Eek, A.; Visser, M. de; Brom, M., et al |
| 2011 | Family history of neurodegenerative and vascular diseases in ALS: a population-based study | Huisman, M.H.; Jong, S.W. de; Verwijs, M.C.; Schelhaas, H.J.; Kooi, A.J. van der, et al |
| 2011 | The phenotype of the Gly94fsX222 PMP22 insertion | Vries, S.D. de; Verhamme, C.; Ruissen, F. van; Paassen, B.W. van; Arts, W.F.M., et al |
| 2010 | FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. | Groen, E.J.; Es, M.A. van; Vught, P.W. van; Spliet, W.G.; Engelen-Lee, J. van, et al |
| 2010 | Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy. | Melis, M.; Swart, J.; Visser, M. de; Berndsen, S.C.; Koelewijn, S., et al |
| 2010 | Exercise therapy and cognitive behavioural therapy to improve fatigue, daily activity performance and quality of life in postpoliomyelitis syndrome: the protocol of the FACTS-2-PPS trial. | Koopman, F.S.; Beelen, A.; Gerrits, K.H.; Bleijenberg, G.; Abma, T.A., et al |
| 2010 | The SNAQ(RC), an easy traffic light system as a first step in the recognition of undernutrition in residential care. | Kruizenga, H.M.; Vet, H.C. de; Marissing, C.M. Van; Stassen, E.E.; Strijk, J.E., et al |
| 2010 | The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. | Menke, L.A.; Sas, T.C.J.; Visser, M. de; Kreukels, B.P.; Stijnen, T., et al |
| 2010 | Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. | Luin, M. van; Ende, M.E. van der; Richter, C.; Visser, M. de; Faraj, D., et al |
| 2010 | Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides. | Melis, M.; Vegt, E.; Konijnenberg, M.W.; Visser, M. de; Bijster, M., et al |
| 2009 | Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. | Trip, J.; Drost, G.; Ginjaar, H.B.; Nieman, F.H.; Kooi, A.J. van der, et al |
| 2009 | International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. | Martinez-Martin, P.; Rodriguez-Blazquez, C.; Abe, K.; Bhattacharyya, K.B.; Bloem, B.R., et al |
| 2009 | Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers. | Yim, C.B.; Boerman, O.C.; Visser, M. de; Jong, M. de; Dechesne, A.C., et al |
| 2009 | The Phenotype of the Gly94Fsx222 Pmp22 Insertion | Vries, S.C. de; Kooi, A.J. van der; Verhamme, C.; Ruissen, F. van; Arts, W.F.M., et al |
| 2009 | Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. | Es, M.A. van; Veldink, J.H.; Saris, C.G.; Blauw, H.M.; Vught, P.W. van, et al |
| 2009 | Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes. | Brugman, F.; Veldink, J.H.; Franssen, H.; Visser, M. de; Jong, J.M. de, et al |
| 2009 | Clinical identification of dysarthria types among neurologists, residents in neurology and speech therapists. | Graaff, M. Van der; Kuiper, T.; Zwinderman, A.; Warrenburg, B.P.C. van de; Poels, P.J.E., et al |
| 2009 | Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. | Piepers, S.; Veldink, J.H.; Jong, S.W. de; Tweel, I. van de; Pol, W.L. van der, et al |
| 2009 | Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. | Es, M.A. van; Vught, P.W. van; Veldink, J.H.; Andersen, P.M.; Birve, A., et al |
| 2009 | Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). | Bodar, E.J.; Simon, A.; Visser, M. de; Meer, J.W.M. van der |
| 2008 | The Lambert-Eaton myasthenic syndrome 1988-2008 : a clinical picture in 97 patients | Titulaer, M.J.; Wirtz, P.W.; Kuks, J.B.; Schelhaas, H.J.; Kooi, A.J. van der, et al |
| 2008 | Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. | Brugman, F.; Scheffer, H.; Wokke, J.H.; Nillesen, W.M.; Visser, M. de, et al |
| 2008 | Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. | Monnier, N.; Marty, I.; Faure, J.; Castiglioni, C.; Desnuelle, C., et al |
| 2008 | A natural history study of late onset spinal muscular atrophy types 3b and 4. | Piepers, S.; Berg, L.H. van den; Brugman, F.; Scheffer, H.; Ruiterkamp-Versteeg, M., et al |
| 2008 | Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a. | Videler, A.J.; Dijk, J.P. van; Beelen, A.; Visser, M. de; Nollet, F., et al |
| 2008 | In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. | Trip, J.; Drost, G.; Verbove, D.J.; Kooi, A.J. van der; Kuks, J.B., et al |
| 2007 | Phenotype of Charcot-Marie-Tooth disease Type 2. | Bienfait, H.M.; Baas, F.; Koelman, J.H.; Haan, R.J. de; Engelen, B.G.M. van, et al |
| 2006 | Long-term outcome in polymyositis and dermatomyositis | Bronner, I.M.; Meulen, M.F. van der; Visser, M. de; Kalmijn, S.; Venrooij, W.J.W. van, et al |
| 2006 | Comparison of CMT1A and CMT2: similarities and differences. | Bienfait, H.M.; Verhamme, C.; Schaik, I.N. van; Koelman, J.H.; Visser, B.W. de, et al |
| 2005 | Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. | Visser, M. de; Ballegooijen, M. van; Bloemers, S.M.; Deventer, S.J.H. van; Jansen, J.B.M.J., et al |
| 2005 | Vier vernieuwingen in de CBO richtlijn myositis. | Jennekens, F.G.I.; Hoogendijk, J.E.; Engelen, B.G.M. van; Coo, I.F.M. de; Hoogen, F.H.J. van den, et al |
| 2005 | [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'] | Hoogendijk, J.E.; Bijlsma, J.W.J.; Engelen, B.G.M. van; Lindeman, E.J.M.; Royen-Kerkhof, A. van, et al |
| 2005 | Inclusion body myositis Clinical features and clinical course of the disease in 64 patients. | Badrising, U.A.; Maat-Schieman, M.L.; Houwelingen, J.C. van; Doorn, P.A. van; Duinen, S.G. van, et al |
| 2005 | Change in serum albumin and subsequent decline in functional status in older persons. | Schalk, B.W.; Visser, M. de; Penninx, B.W.; Baadenhuijsen, H.; Bouter, L.M., et al |
| 2004 | Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. | Badrising, U.A.; Schreuder, G.M.; Giphart, M.J.; Geleijns, K.; Verschuuren, J.J., et al |
| 2004 | The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. | Wirtz, P.W.; Dijk, J.G. van; Doorn, P.A. van; Engelen, B.G.M. van; Kooi, A.J. van der, et al |
| 2004 | Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease. | Martin, M.A.; Rubio, J.C.; Wevers, R.A.; Engelen, B.G.M. van; Steenbergen-Spanjers, G.C.H., et al |
| 1997 | Vocational perspectives and neuromuscular disorders | Andries, F.; Wevers, C.W.J.; Wintzen, A.R.; Busch, H.F.M.; Höweler, C.J., et al |
| 1996 | Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease | Gabreëls-Festen, A.A.W.M.; Hoogendijk, J.E.; Meijerink, P.H.S.; Gabreëls, F.J.M.; Bolhuis, P.A., et al |
| 1996 | The clinical spectrum of limb girdle muscular dystrophy : a survey in the Netherlands | Kooi, A.J. van der; Barth, P.G.; Busch, H.F.M.; Haan, R.J. de; Ginjaar, H.B., et al |
| 1996 | Two divergent types of nerve pathology in patients with different Po mutations in Charcot-Marie-Tooth disease | Gabreëls-Festen, A.A.W.M.; Hoogendijk, J.E.; Meijerink, P.H.S.; Gabreëls, F.J.M.; Bolhuis, P.A., et al |
| 1996 | Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies | Meijerink, P.H.S.; Hoogendijk, J.E.; Gabreëls-Festen, A.A.W.M.; Zorn, I.; Veldman, H., et al |
| 1995 | Ziekte van Wilson; ontmaskering met behulp van kernspinresonantie-tomografie | Berg, J.S.P. van den; Hoogenraad, T.U.; Duyn, J.A.; Verbeeten, B.; Aalfs, C.M., et al |
Showing results 1 to 44 of 44
|